EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral KDS2010 , a Monoamine Oxidase‐B ( MAO ‐B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO‐B‐Mediated Inflammation

Dong Ho Woo iD, Ju-Hyun Jeon, Hye-Jin Ryu, Gyeong Min Lee, Hye-Won Lim, Ki Duk Park, Kwang Lae Hoe, Sang Dal Rhee

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Dong Ho Woo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Biopharmaceutical Research, Korea Institute of Toxicology, Daejeon, South Korea. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Spinocerebellar Ataxias, Astrocytes, Monoamine Oxidase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder characterized by balance and gait disturbance, muscle coordination deficits, and dysarthria as a primary symptom. SCA1 is caused by the expansion of CAG repeats in the ATXN1 gene, leading to a polyglutamine(polyQ) tract in the Ataxin‐1 protein. In this study, the effects of KDS2010, an inhibitor of monoamine oxidase‐B (MAO‐B), were evaluated in a transgenic mouse model of SCA1 (SCA1 154Q/2Q ) disease model using the rotarod, hindlimb, and open field tests. In both males and females, oral administration of KDS2010 significantly improved latency in the rotarod test and the hindlimb clasping phenotype without changing muscle weight. In the open field test, a notable improvement in moving distance was observed particularly in females. Treatment with KDS2010 slowed molecular layer atrophy and restored the reduced number of Purkinje cells in the cerebellum of SCA1 model mice, accompanied by decreased levels of glial fibrillary acidic protein (GFAP) and reduced expression of monoamine oxidase‐B (MAO‐B). These results indicate that KDS2010 ameliorated the behavioral pathology of SCA1 by attenuating GFAP upregulation and preventing Purkinje cell loss. Our findings demonstrate that KDS2010 improves SCA1‐related behavioral deficits by reducing GFAP expression, preserving Purkinje cell numbers, and decreasing cerebellar MAO‐B levels—molecular markers of SCA1, without affecting muscle size. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoamine Oxidase InhibitorsSpinocerebellar AtaxiasAstrocytesMonoamine OxidaseAnimalsMice, TransgenicMiceMaleFemaleAdministration, OralDisease Models, AnimalAtaxin-1InflammationMice, Inbred C57BLMotor Activity

Stichwörter der Autor:innen

GFAPKDS2010MAO‐BSCA1

Substanzen

Monoamine Oxidase InhibitorsMonoamine OxidaseAtaxin-1

Autor:innen und Institutionen

  • Center for Global Biopharmaceutical Research, Korea Institute of Toxicology, Daejeon, South Korea.
  • Human and Environmental Toxicology, University of Science and Technology, Daejeon, Republic of Korea.
  • Center for the Rare Disease Therapeutic Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
  • Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.
  • Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea.

ORCID-Profile: Dong Ho Woo

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Woo, D. H., Jeon, J. H., Ryu, H. J., Lee, G. M., Lim, H. W., Park, K. D., Hoe, K. L., & Rhee, S. D. (2025). Oral KDS2010 , a Monoamine Oxidase‐B ( MAO ‐B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO‐B‐Mediated Inflammation. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70302

Vancouver

Woo DH, Jeon JH, Ryu HJ, Lee GM, Lim HW, Park KD, et al. Oral KDS2010 , a Monoamine Oxidase‐B ( MAO ‐B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO‐B‐Mediated Inflammation. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70302

BibTeX
@article{Woo2025,
  author = {Woo, Dong Ho and Jeon, Ju-Hyun and Ryu, Hye-Jin and Lee, Gyeong Min and Lim, Hye-Won and Park, Ki Duk and Hoe, Kwang Lae and Rhee, Sang Dal},
  title = {Oral KDS2010 , a Monoamine Oxidase‐B ( MAO ‐B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO‐B‐Mediated Inflammation},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70302}
}
Kostenlos starten →